{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:15:07Z","timestamp":1790745307563,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.ando.2018.03.004","type":"journal-article","created":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T19:06:13Z","timestamp":1525374373000},"page":"107-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"title":["Glucocorticoid receptor modulators"],"prefix":"10.1016","volume":"79","author":[{"given":"Onno C.","family":"Meijer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa L.","family":"Koorneef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Kroon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2018.03.004_bib0270","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrn1683","article-title":"Stress and the brain: from adaptation to disease","volume":"6","author":"De Kloet","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.ando.2018.03.004_bib0275","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.yfrne.2013.09.005","article-title":"Why do we need nongenomic glucocorticoid mechanisms?","volume":"35","author":"Jiang","year":"2014","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.ando.2018.03.004_bib0280","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ejphar.2007.11.076","article-title":"Selective transrepression versus transactivation mechanisms by glucocorticoid receptor modulators in stress and immune systems","volume":"583","author":"De Bosscher","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ando.2018.03.004_bib0285","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1371\/journal.pgen.0010016","article-title":"Glucocorticoid receptor-dependent gene regulatory networks","volume":"1","author":"Phuc Le","year":"2005","journal-title":"PLoS Genet"},{"key":"10.1016\/j.ando.2018.03.004_bib0290","doi-asserted-by":"crossref","first-page":"17582","DOI":"10.1073\/pnas.0909733106","article-title":"Glucocorticoid regulation of the circadian clock modulates glucose homeostasis","volume":"106","author":"So","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ando.2018.03.004_bib0295","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nn.3275","article-title":"Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions","volume":"16","author":"Klengel","year":"2013","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.ando.2018.03.004_bib0300","doi-asserted-by":"crossref","first-page":"15603","DOI":"10.1073\/pnas.0407008101","article-title":"Chromatin immunoprecipitation (ChIP) scanning identifies primary glucocorticoid receptor target genes","volume":"101","author":"Wang","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ando.2018.03.004_bib0305","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.cell.2011.03.027","article-title":"Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor","volume":"145","author":"Surjit","year":"2011","journal-title":"Cell Res"},{"key":"10.1016\/j.ando.2018.03.004_bib0310","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1101\/gad.1297105","article-title":"The glucocorticoid receptor blocks P-TEFb recruitment by NFkappaB to effect promoter-specific transcriptional repression","volume":"19","author":"Luecke","year":"2005","journal-title":"Genes Dev"},{"key":"10.1016\/j.ando.2018.03.004_bib0315","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1210\/en.2016-1422","article-title":"NeuroD factors discriminate mineralocorticoid from glucocorticoid receptor DNA binding in the male rat brain","volume":"158","author":"van Weert","year":"2017","journal-title":"Endocrinology [Internet]"},{"key":"10.1016\/j.ando.2018.03.004_bib0320","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1210\/en.2016-1929","article-title":"Genome-wide identification of basic helix-loop helix and NF-1 motifs underlying GR binding sites in male rat hippocampus","volume":"158","author":"Pooley","year":"2017","journal-title":"Endocrinology [Internet]"},{"key":"10.1016\/j.ando.2018.03.004_bib0325","doi-asserted-by":"crossref","first-page":"15827","DOI":"10.1073\/pnas.0505554102","article-title":"A fully dissociated compound of plant origin for inflammatory gene repression","volume":"102","author":"De Bosscher","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ando.2018.03.004_bib0330","doi-asserted-by":"crossref","first-page":"e0188810","DOI":"10.1371\/journal.pone.0188810","article-title":"Efficacy and safety of selective glucocorticoid receptor modulators in comparison to glucocorticoids in arthritis, a systematic review","volume":"12","author":"Safy","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ando.2018.03.004_bib0335","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejphar.2017.03.057","article-title":"JTP-117968, a novel selective glucocorticoid receptor modulator, exhibits improved transrepression\/transactivation dissociation","volume":"803","author":"Kurimoto","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ando.2018.03.004_bib0340","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1535-6108(04)00059-5","article-title":"Selective estrogen receptor modulation: concept and consequences in cancer","volume":"5","author":"Jordan","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ando.2018.03.004_bib0345","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1210\/me.2007-0012","article-title":"Coregulators: from whence came these \u201cmaster genes\u201d","volume":"21","author":"O\u2019Malley","year":"2007","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.ando.2018.03.004_bib0350","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/nrendo.2012.100","article-title":"nrendo.2012.100","volume":"8","author":"Lonard","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ando.2018.03.004_bib0355","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1073\/pnas.1520376113","article-title":"Genome-wide coexpression of steroid receptors in the mouse brain: identifying signaling pathways and functionally coordinated regions","volume":"113","author":"Mahfouz","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ando.2018.03.004_bib0360","doi-asserted-by":"crossref","first-page":"8038","DOI":"10.1073\/pnas.0812062106","article-title":"Steroid receptor coactivator-1 is necessary for regulation of corticotropin-releasing hormone by chronic stress and glucocorticoids","volume":"106","author":"Lachize","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ando.2018.03.004_bib0365","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1038\/mp.2016.16","article-title":"Isoform switching of steroid receptor co-activator-1 attenuates glucocorticoid-induced anxiogenic amygdala CRH expression","volume":"21","author":"Zalachoras","year":"2016","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.ando.2018.03.004_bib0370","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1210\/er.2003-0023","article-title":"Coregulator function: a key to understanding tissue specificity of selective receptor modulators","volume":"25","author":"Smith","year":"2004","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ando.2018.03.004_bib0375","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1210\/me.2002-0355","article-title":"A novel antiinflammatory maintains glucocorticoid efficacy with reduced side effects","volume":"17","author":"Coghlan","year":"2003","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.ando.2018.03.004_bib0380","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/42750","article-title":"A signature motif in transcriptional co-activators mediates binding to nuclear receptors","volume":"387","author":"Heery","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.ando.2018.03.004_bib0385","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1074\/mcp.M900209-MCP200","article-title":"Nuclear receptor-coregulator interaction profiling identifies TRIP3 as a novel peroxisome proliferator-activated receptor gamma cofactor","volume":"8","author":"Koppen","year":"2009","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.ando.2018.03.004_bib0390","doi-asserted-by":"crossref","first-page":"7910","DOI":"10.1073\/pnas.1219411110","article-title":"Differential targeting of brain stress circuits with a selective glucocorticoid receptor modulator","volume":"110","author":"Zalachoras","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ando.2018.03.004_bib0395","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1210\/en.2015-1390","article-title":"A mixed glucocorticoid\/mineralocorticoid selective modulator with dominant antagonism in the male rat brain","volume":"156","author":"Atucha","year":"2015","journal-title":"Endocrinology"},{"issue":"1279","key":"10.1016\/j.ando.2018.03.004_bib0400","first-page":"0","article-title":"Point mutation in the mouse glucocorticoid receptor preventing DNA binding impairs spatial memory","volume":"98","author":"Oitzl","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ando.2018.03.004_bib0405","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.yhbeh.2014.02.002","article-title":"The selective glucocorticoid receptor antagonist CORT 108297 decreases neuroendocrine stress responses and immobility in the forced swim test","volume":"65","author":"Solomon","year":"2014","journal-title":"Horm Behav"},{"key":"10.1016\/j.ando.2018.03.004_bib0410","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/bph.13477","article-title":"Identification of a selective glucocorticoid receptor modulator that prevents both diet-induced obesity and inflammation","volume":"173","author":"van den Heuvel","year":"2016","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ando.2018.03.004_bib0415","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1210\/en.2017-00468","article-title":"DNA sequence constraints define functionally active steroid nuclear receptor binding sites in chromatin","volume":"158","author":"Coons","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.ando.2018.03.004_bib0420","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1210\/en.2011-0287","article-title":"Specific regulatory motifs predict glucocorticoid responsiveness of hippocampal gene expression","volume":"152","author":"Datson","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.ando.2018.03.004_bib0425","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.tips.2015.09.002","article-title":"Activation of the glucocorticoid receptor in acute inflammation: the SEDIGRAM concept","volume":"37","author":"De Bosscher","year":"2016","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.ando.2018.03.004_bib0430","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","article-title":"Cushing's syndrome","volume":"386","author":"Lacroix","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ando.2018.03.004_bib0435","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1196\/annals.1367.012","article-title":"Tissue production of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 and metabolic disease","volume":"1083","author":"Walker","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ando.2018.03.004_bib0440","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1210\/en.2017-00512","article-title":"Selective glucocorticoid receptor antagonist CORT125281 activates brown adipose tissue and alters lipid distribution in male mice","volume":"159","author":"Kroon","year":"2018","journal-title":"Endocrinology"},{"key":"10.1016\/j.ando.2018.03.004_bib0445","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1172\/JCI79828","article-title":"Glucocorticoid receptor antagonism decreases alcohol seeking in alcohol-dependent individuals","volume":"125","author":"Vendruscolo","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ando.2018.03.004_bib0450","doi-asserted-by":"crossref","first-page":"9047","DOI":"10.1523\/JNEUROSCI.2797-06.2006","article-title":"Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer's disease","volume":"26","author":"Green","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.ando.2018.03.004_bib0455","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.1158\/1078-0432.CCR-12-3826","article-title":"Glucocorticoid receptor antagonism as a novel therapy for triple-negative breast cancer","volume":"19","author":"Skor","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ando.2018.03.004_bib0460","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1530\/ERC-15-0343","article-title":"Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer","volume":"23","author":"Kroon","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ando.2018.03.004_bib0465","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1158\/1535-7163.MCT-16-0923","article-title":"Selective glucocorticoid receptor modulators (SGRMs) delay castrate-resistant prostate cancer growth","volume":"16","author":"Kach","year":"2017","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.ando.2018.03.004_bib0470","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.neurobiolaging.2016.05.018","article-title":"New selective glucocorticoid receptor modulators reverse amyloid-\u03b2 peptide-induced hippocampus toxicity","volume":"45","author":"Pineau","year":"2016","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.ando.2018.03.004_bib0475","doi-asserted-by":"crossref","first-page":"e91248","DOI":"10.1371\/journal.pone.0091248","article-title":"Effects of selective and non-selective glucocorticoid receptor II antagonists on rapid-onset diabetes in young rats","volume":"9","author":"Beaudry","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ando.2018.03.004_bib0480","first-page":"1","article-title":"Discovery of a novel non-steroidal GR antagonist with in vivo efficacy in the olanzapine-induced weight gain model in the rat","author":"Hunt","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ando.2018.03.004_bib0485","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jsbmb.2014.02.007","article-title":"The selective glucocorticoid receptor modulator CORT108297 restores faulty hippocampal parameters in Wobbler and corticosterone-treated mice","volume":"143","author":"Meyer","year":"2014","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.ando.2018.03.004_bib0490","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/1043-2760(91)90030-Q","article-title":"The antisteroid RU486: its cellular and molecular mode of action","volume":"2","author":"Baulieu","year":"1991","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.ando.2018.03.004_bib0495","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1016\/j.bmcl.2015.10.097","article-title":"1H-Pyrazolo[3,4-g]hexahydro-isoquinolines as potent GR antagonists with reduced hERG inhibition and an improved pharmacokinetic profile","volume":"25","author":"Hunt","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ando.2018.03.004_bib0500","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.bmcl.2008.01.027","article-title":"1H-Pyrazolo[3,4-g]hexahydro-isoquinolines as selective glucocorticoid receptor antagonists with high functional activity","volume":"18","author":"Clark","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ando.2018.03.004_bib0505","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1021\/acs.jmedchem.7b00162","volume":"60","author":"Hunt","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.ando.2018.03.004_bib0510","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/ijo.2016.13","article-title":"A novel combined glucocorticoid-mineralocorticoidreceptor selective modulator markedly prevents weightgain and fat mass expansion in mice fed a high-fat diet","volume":"40","author":"Mammi","year":"2016","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.ando.2018.03.004_bib0515","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1210\/me.2012-1324","article-title":"Research resource: tissue- and pathway-specific metabolomic profiles of the steroid receptor coactivator (SRC) family","volume":"27","author":"York","year":"2013","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.ando.2018.03.004_bib0520","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nature05453","article-title":"Genome-wide atlas of gene expression in the adult mouse brain","volume":"445","author":"Lein","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ando.2018.03.004_bib0525","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1210\/mend.16.1.0753","article-title":"AR and ER interaction with a p21-activated kinase (PAK6)","volume":"16","author":"Lee","year":"2002","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.ando.2018.03.004_bib0530","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ydbio.2008.07.006","article-title":"Targeted disruption of the Pak5 and Pak6 genes in mice leads to deficits in learning and locomotion","volume":"322","author":"Nekrasova","year":"2008","journal-title":"Dev Biol"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426618300295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426618300295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:50:19Z","timestamp":1757717419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426618300295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0003426618300295"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2018.03.004","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucocorticoid receptor modulators","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2018.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}